News

European GDP Association Developments January through April 2026

Find out what the European GDP Association was working on and accomplished in the first four months of 2026 - in the latest report.

More
IPEC: Updated Stability Guide for Excipients

At the end of March 2026, the IPEC announced the updated Version 3 of its 'Excipient Stability Guide for Pharmaceutical Excipients' in a notice on its website. This was first published in 2010 and is currently only available and viewable in the IPEC members' area. Following a three-month period (expected to end on 30 June 2026), the updated guide is to be published in full.

More
Implementation of GDP for Pharmaceutical Products in Hong Kong

The Pharmacy and Poisons Board of Hong Kong has launched a public consultation on implementing Good Distribution Practice (GDP) for pharmaceutical products in Hong Kong by adopting the PIC/S GDP Guide. Stakeholders are invited to comment on the draft guidance documents. The consultation period runs from 1 April to 31 May 2026.

More
China's NMPA: Guiding Opinions & Q&A on Standardising Modern Pharmaceutical Logistics

China’s National Medical Products Administration (NMPA) has issued new Guiding Opinions on the standardisation of modern pharmaceutical logistics, accompanied by an official Q&A document to address key industry questions.

More
GMDP IWG Three-Year Work Plan: What's Planned for GDP?

The European Medicines Agency (EMA) has published on its website the 3-year work plan (2026–2028) of the GMDP Inspectors Working Group (GMDP IWG) as well as the 2025 annual report. In addition to numerous GMP-related topics, both documents also highlight important aspects that are relevant to the GDP area.

More
Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 2

Around 120 participants attended the ECA Webinar “GDP Update 2026” in March. Many interesting aspects were discussed during the Q&A session. After the event, the speaker, Dr Christian Grote-Westrick, provided written responses to the submitted questions. We have compiled a selection of these questions and answers for you – read Part 2 here, focusing on temperature control.

More
What is Good Distribution Practice (GDP)?

Good Distribution Practice (GDP) ensures that medicinal products maintain their quality, safety, and efficacy throughout the entire supply chain. Consistent implementation is a prerequisite for compliance, patient safety, and successful inspections.

More
FIFO, FEFO, LIFO: What is the meaning?

FIFO, FEFO and LIFO are the three main strategies for warehouse management. But what do the three abbreviations actually stand for and what exactly do they mean?

More
Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 1

Around 120 participants attended the ECA Webinar “GDP Update 2026” in March. Many interesting aspects were discussed during the Q&A session. After the event, the speaker, Dr Christian Grote-Westrick, provided written responses to the submitted questions. We have compiled a selection of these questions and answers for you – read Part 1 here, covering the topics of returns/Swissmedic, the USA, and HPRA.

More
What Requirements must a Responsible Person for GDP meet?

According to the EU Guidelines on Good Distribution Practice (GDP), a wholesale distributor must designate a Responsible Person (RP). The RP plays a key role in ensuring GDP-compliant distribution of medicinal products and can effectively fulfil this role only if appropriately qualified and experienced, and vested with the necessary authority and personal integrity.

More
x
Search